DNA Test for Antidepressants Raises FDA Doubts; Myriad Drops - Bloomberg

Submitted by Anonymous (not verified) on Wed, 08/14/2019 - 16:45

DNA Test for Antidepressants Raises FDA Doubts; Myriad Drops  BloombergA company that helped pioneer genetic tests used to diagnose and treat disease lost more than 40% of its value on Wednesday, after U.S. regulators raised ...